| Ytd | 50.94% | |
| 1y | -13.51% |
| Open | 1.55 | Prev Close | 1.63 | Low | 1.51 | High | 1.61 | Mkt Cap | 8.79M |
| Vol | 36.68K | Avg Vol | 70.15K | EPS | -2.84 | P/E | N/A | Forward P/E | -0.75 |
| Beta | 0.71 | Short Ratio | 0.12 | Inst. Own | 8.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.38 | 200-d Avg | 1.20 | 1yr Est | 20.00 |
Vancouver, British Columbia--(Newsfile Corp. - October 26, 2026) - InMed Pharmaceuticals Inc. (NASDA
InMed Pharmaceuticals Inc. (NASDAQ: INM - Get Free Report) was the recipient of a significant declin
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2026) - InMed Pharmaceuticals Inc. (NAS
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - InMed Pharmaceuticals Inc. (NASD
InMed Pharmaceuticals (NASDAQ: INM - Get Free Report) and Reviva Pharmaceuticals (NASDAQ: RVPH - Get
Mentari Therapeutics, a privately held biotechnology enterprise dedicated to preventing migraines, h
Mentari Therapeutics secures $200 million in private financing before merging with InMed Pharmaceuti
Gainers Advanced Biomed (NASDAQ:ADVB) shares moved upwards by 108.6% to $14.77 during Wednesday'
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#
WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Mentari Therapeutics, Inc. ("Mentari"), a privately-he
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-mark
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia and San Francisco, California--(Newsfile Corp. - July 6, 2026) - InMed P
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: I
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & A
BALA CYNWYD, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it i
/C O R R E C T I O N -- InMed Pharmaceuticals/ PR Newswire VANCOUVER, BC and SAN FRANCISCO, May 19,
US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of InMed Pharmaceuticals,
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports
InMed agrees to merge with Mentari Therapeutics to advance migraine drug candidates backed by $290 m
About the Proposed TransactionUnder the terms of the merger agreement, as of the closing of the prop
Upon consummation of the transaction contemplated by the Agreement, the combined entity will operate
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursda
Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of